Pneumococcal Vaccines Market Next Big Thing | Major Giants AstraZeneca, SutroVax, Sanofi Pasteur

A new independent 32 page research with title 'Pneumococcal Vaccines: Epidemiology Forecast in Asia-Pacific Markets to 2028' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe, Asia-Pacific and important players/vendors such as Pfizer, Inc. (United States), Sanofi Pasteur (France), GlaxoSmithKline plc (United Kingdom), Merck & Co., Inc. (United States) etc. With n-number of tables and figures examining the Pneumococcal Vaccines, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader's market revenue forecasts as well as analysis to 2022

Get customization & check discount for report @ https://www.htfmarketreport.com/request-discount/2584360-pneumococcal-vaccines-2
Summary

Streptococcus pneumoniae (S. pneumoniae) is a bacterial organism that causes a number of diseases, ranging from serious to mild infections. Symptoms depend on the part of the body that is infected, and range from fever, chills, and difficulty breathing to stiff neck and confusion. Transmission of S. pneumoniae primarily occurs through respiratory droplets. The term invasive pneumococcal disease (IPD) refers to more severe infections in which the bacterium is isolated from normally sterile sites. IPD is most common in high-risk groups, such as young children and the elderly, where the immune system is more vulnerable.

GlobalData epidemiologists utilized comprehensive, country-specific pneumococcal vaccination rate data and IPD diagnosed incidence rate data from nationally representative public health surveillance systems and databases to arrive at a meaningful, in-depth epidemiological analysis and forecast. Moreover, GlobalData epidemiologists provide detailed dose- and age-specific pneumococcal vaccination rates that are dependent on the routine immunization requirements of each market.

Request a sample report @ https://www.htfmarketreport.com/sample-report/2584360-pneumococcal-vaccines-2
GlobalData epidemiologists forecast that the pneumococcal vaccinated pediatric population in the 5GM will increase from 20,087,973 children vaccinated in 2018 to 22,139,213 children vaccinated in 2028. In the elderly population in four growth markets (4GM: Australia, Japan, South Korea, and urban China) where vaccination in this age group is recommended, GlobalData epidemiologists forecast an increase from 27,444,336 elderly vaccinated in 2018 to 39,002,217 elderly vaccinated in 2028. In the 5GM in 2018, the average pediatric vaccination rate was approximately 75%, while in the 4GM, the average elderly vaccination rate was approximately 45%. Additionally, GlobalData epidemiologists forecast that the diagnosed incident cases of IPD in the 5GM will decrease from 2,038,634 cases in 2018 to 1,880,503 cases in 2028. In the future, continued efforts should focus on establishing national vaccine initiatives and goals and carrying out a targeted, actionable, and effective country-specific approach to overcome vaccine hesitancy, increase vaccine awareness, and ultimately reduce IPD incidence worldwide.

Scope

- The Pneumococcal Vaccines Epidemiology report provide an overview of the risk factors and global trends of pneumococcal vaccines in the five growth markets (5GM: Australia, India, Japan, South Korea, and urban China).
- This report also includes a 10-year epidemiological forecast for the vaccinated pneumococcal population segmented by age (pediatric and elderly), and diagnosed incident cases of IPD segmented by age (0-4 years, 5-9 years, 10-19 years, and by 10-year age groups up to 80 years and older). Pneumococcal vaccine dosing and age groups included within the forecast were dependent on the routine immunization requirements in each market and the availability of vaccination data. In addition, the epidemiology model corresponding to this report provides IPD diagnosed incident cases segmented into the top ten most common IPD serotypes by age (pediatric and elderly).
- The Pneumococcal Vaccines epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 5GM.

Place a Purchase Order for this Market Study (Single User License) at: https://www.htfmarketreport.com/buy-now?format=1&report=2584360
Reasons to Buy

- The Pneumococcal Vaccines Epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global pneumococcal vaccines market.
- Quantify patient populations in the global pneumococcal vaccines market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for pneumococcal vaccine therapeutics in each of the markets covered.
- Understand magnitude of the pneumococcal vaccines population by dose and age.

Companies Mentioned in the Report

Pfizer, Inc. (United States), Sanofi Pasteur (France), GlaxoSmithKline plc (United Kingdom), Merck & Co., Inc. (United States), AstraZeneca plc (United Kingdom), Serum Institute of India Pvt. Ltd (India), SutroVax Inc. (United States) and Chengdu Institute of Biological Products (China)

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Pneumococcal Vaccines: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.3.1 Pediatric and Elderly Pneumococcal Vaccination Rates
3.3.2 Diagnosed Incidence of Invasive Pneumococcal Disease (Cases per 100,000 Population)
3.4 Forecast Methodology
3

....Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2584360-pneumococcal-vaccines-2

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA - 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the "Accurate Forecast" in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their "Goals & Objectives".

This release was published on openPR.